ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics,
NEW YORK, July 03, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Regulation Agency, a world investor rights legislation agency, reminds purchasers of the securities of Axsome Therapeutics, Inc. (NASDAQ: AXSM) between December 30, 2019 and April…